Stang E, Krause J, Seydel W, Berg T, Roos N
Department of Biology, University of Oslo, Norway.
Biochem J. 1992 Mar 15;282 ( Pt 3)(Pt 3):841-51. doi: 10.1042/bj2820841.
Endocytosis of tissue-type plasminogen activator (t-PA) by different types of rat liver cells was studied in immunocytochemically labelled cryosections as well as in biochemical experiments. For morphological localization of the ligand in different endocytic compartments involved in its catabolism, rat livers were fixed at various times (1-24 min) after injection of t-PA. Late-endosomal and lysosomal compartments were identified by double-labelling the sections with antibodies to the lysosomal proteins glycoprotein Igp 120 and cathepsin D. In liver t-PA was localized in sinusoidal endothelial cells (EC), parenchymal cells (PC) and to some extent in Kupffer cells (KC), indicating that it is internalized and degraded in all three cell types. In specimens fixed 6 min after injection PC, EC and KC were found to contribute to 69, 24 and 7% respectively of total t-PA endocytosed. The transfer from late endosomes to lysosomes was found to be faster in EC than in PC. The morphological findings were supported by studies of the endocytic mechanisms employing isolated perfused livers and primary hepatocytes. The presence of monensin, an inhibitor of lysosomal protein degradation, reduced the amount of t-PA degraded to about 50% of the control values. The catalytic site seems not to be required for the catabolism of t-PA in hepatic cells. The inhibition of t-PA by D-phenylalanyl-L-prolylarginyl-chloromethane did not influence receptor recognition and catabolic processing, as determined in morphological studies using labelled cryosections, in binding studies employing liver cell membranes and primary hepatocytes, as well as in liver-perfusion experiments.
在免疫细胞化学标记的冰冻切片以及生化实验中,研究了不同类型大鼠肝细胞对组织型纤溶酶原激活剂(t-PA)的内吞作用。为了在参与其分解代谢的不同内吞区室中对配体进行形态学定位,在注射t-PA后的不同时间点(1 - 24分钟)固定大鼠肝脏。通过用针对溶酶体蛋白糖蛋白Igp 120和组织蛋白酶D的抗体对切片进行双重标记来鉴定晚期内体和溶酶体区室。在肝脏中,t-PA定位于窦状内皮细胞(EC)、实质细胞(PC),并在一定程度上定位于库普弗细胞(KC),这表明它在所有这三种细胞类型中都被内化和降解。在注射后6分钟固定的标本中,发现PC、EC和KC分别占总内吞t-PA的69%、24%和7%。发现从晚期内体向溶酶体的转运在EC中比在PC中更快。采用离体灌注肝脏和原代肝细胞的内吞机制研究支持了形态学发现。溶酶体蛋白降解抑制剂莫能菌素的存在使t-PA降解量减少至对照值的约50%。肝细胞中t-PA的分解代谢似乎不需要催化位点。如在使用标记冰冻切片的形态学研究、使用肝细胞膜和原代肝细胞的结合研究以及肝脏灌注实验中所确定的,D-苯丙氨酰-L-脯氨酰精氨酰氯甲烷对t-PA的抑制并不影响受体识别和分解代谢过程。